SCHEMBL7084466

SCHEMBL7084466

COP(=O)(OC)C(Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)P(=O)(OC)OC

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 11/20 0.74
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
GAA P10253 2/20 0.46
ALDH1A1 P00352 3/20 0.44
TSHR P16473 3/20 0.44
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
MAPK1 P28482 2/20 0.44
BLM P54132 2/20 0.44
ATM Q13315 2/20 0.44
HIF1A Q16665 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
USP2 O75604 1/20 0.44
CYP2D6 P10635 1/20 0.44
MAPT P10636 1/20 0.44
LMNA P02545 2/20 0.44
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
GMNN O75496 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1704691 0.85 HMGCR (1.00) HMGCRMEN1KMT2AGAAALDH1A1
Apomine SCHEMBL1648488 0.85 HMGCR (1.00) HMGCR
SCHEMBL7083916 0.82 HMGCR (0.80) HMGCRMEN1KMT2AGAAALDH1A1
SCHEMBL6370947 0.82 HMGCR (0.66) HMGCRMEN1KMT2AGAAALDH1A1
SCHEMBL7134552 0.80 HMGCR (0.76) HMGCRMEN1KMT2AGAAALDH1A1
SCHEMBL7086384 0.77 HMGCR (0.85) HMGCRMEN1KMT2AGAACYP1A2
SCHEMBL7086181 0.77 HMGCR (0.85) HMGCR
SCHEMBL8154654 0.77 HMGCR (0.59) HMGCRMEN1KMT2AGAAALDH1A1
SCHEMBL7701583 0.76 HMGCR (0.54) HMGCRMEN1KMT2AGAAALDH1A1
SCHEMBL911756 0.76 MEN1 (0.56) HMGCRMEN1KMT2AGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326618-A2 USE OF ARYL-SUBSTITUTED 1,1-DIPHOSPHONATES FOR THE TREATMENT OF BONE DISEASES Ilex Oncology Research S.A. (CH) 2003-07-16 EP claimed
WO-2002011704-A2 USE OF ARYL-SUBSTITUTED 1,1-DIPHOSPHONATES FOR THE TREATMENT OF BONE DISEASES SYMPHAR S.A. (CH) 2002-02-14 WO claimed
EP-0845991-B1 USE OF PHENOL SUBSTITUTED DIPHOSPHONATES AS ANTINEOPLASTIC AGENTS SYMPHAR SA (CH) 2002-02-06 EP claimed
US-6127350-A FOR TREATMENT AND PREVENTION OF RAS ONCOGENE DEPENDENT CANCERS AND METASTATIC INVASIONS SYMPHAR S.A. (SE) 2000-10-03 US claimed